Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

Overview

Journal Clin Med Insights Pediatr

Publisher Sage Publications

Specialty Pediatrics

Date 2018 Dec 22

PMID 30574005

Citations 34

Authors

Zoe Michael

Fotios Spyropoulos

Sailaja Ghanta

Helen Christou

Affiliations

Soon will be listed here.

Abstract

Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of surviving extremely preterm infants and is associated with significant health care utilization in infancy and beyond. Recent advances in neonatal care have resulted in improved survival of extremely low birth weight (ELBW) infants; however, the incidence of BPD has not been substantially impacted by novel interventions in this vulnerable population. The multifactorial cause of BPD requires a multi-pronged approach for prevention and treatment. New approaches in assisted ventilation, optimal nutrition, and pharmacologic interventions are currently being evaluated. The focus of this review is the current state of the evidence for pharmacotherapy in BPD. Promising future approaches in need of further study will also be reviewed.

Citing Articles

L-Citrulline in Neonates: From Bench to Bed Side.

Mascarenhas D, Mohammadi A, Higazy R, Ivanovska J, Gauda E, Jasani B Children (Basel). 2025; 12(1).

PMID: 39857873 PMC: 11763423. DOI: 10.3390/children12010042.

miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options.

Maeda H, Li X, Go H, Dennery P, Yao H Front Biosci (Landmark Ed). 2024; 29(7):271.

PMID: 39082345 PMC: 11799892. DOI: 10.31083/j.fbl2907271.

Predictive and Diagnostic Values of Systemic Inflammatory Indices in Bronchopulmonary Dysplasia.

Cao L, Liu X, Sun T, Zhang Y, Bao T, Cheng H Children (Basel). 2024; 11(1).

PMID: 38255338 PMC: 10814477. DOI: 10.3390/children11010024.

Furin Regulates the Alveolarization of Neonatal Lungs in a Mouse Model of Hyperoxic Lung Injury.

Kato S, Iwata O, Kato H, Fukaya S, Imai Y, Saitoh S Biomolecules. 2023; 13(11).

PMID: 38002338 PMC: 10669361. DOI: 10.3390/biom13111656.

L-citrulline attenuates lipopolysaccharide-induced inflammatory lung injury in neonatal rats.

Ivanovski N, Wang H, Tran H, Ivanovska J, Pan J, Miraglia E Pediatr Res. 2023; 94(5):1684-1695.

PMID: 37349511 DOI: 10.1038/s41390-023-02684-1.

References

Fung M, Thebaud B . Stem cell-based therapy for neonatal lung disease: it is in the juice. Pediatr Res. 2013; 75(1-1):2-7. PMC: 3940470. DOI: 10.1038/pr.2013.176. View

Lauterbach R, Szymura-Oleksiak J, Pawlik D, Warchol J, Lisowska-Miszczyk I, Rytlewski K . Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study. J Matern Fetal Neonatal Med. 2006; 19(7):433-8. DOI: 10.1080/14767050600736754. View

Howlett A, Ohlsson A, Plakkal N . Inositol in preterm infants at risk for or having respiratory distress syndrome. Cochrane Database Syst Rev. 2015; (2):CD000366. DOI: 10.1002/14651858.CD000366.pub3. View

Wang E, Ohlsson A, Kellner J . Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr. 1995; 127(4):640-4. DOI: 10.1016/s0022-3476(95)70130-3. View

Levine C, Gewolb I, Allen K, Welch R, Melby J, Pollack S . The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res. 2005; 58(1):15-21. DOI: 10.1203/01.PDR.0000156371.89952.35. View

Shinwell E, Portnov I, Meerpohl J, Karen T, Bassler D . Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis. Pediatrics. 2016; 138(6). DOI: 10.1542/peds.2016-2511. View

Keller R, Eichenwald E, Hibbs A, Rogers E, Wai K, Black D . The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017; 183:19-25.e2. PMC: 5367937. DOI: 10.1016/j.jpeds.2016.12.059. View

Aghai Z, Kode A, Saslow J, Nakhla T, Farhath S, Stahl G . Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res. 2007; 62(4):483-8. DOI: 10.1203/PDR.0b013e318142582d. View

Zhang P, Lavoie P, Lacaze-Masmonteil T, Rhainds M, Marc I . Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics. 2014; 134(1):120-34. DOI: 10.1542/peds.2014-0459. View

10.

Carpenter T, Stenmark K . Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Pediatr Infect Dis J. 2004; 23(1 Suppl):S33-40. DOI: 10.1097/01.inf.0000108191.13799.09. View

11.

Kribs A, Roll C, Gopel W, Wieg C, Groneck P, Laux R . Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2015; 169(8):723-30. DOI: 10.1001/jamapediatrics.2015.0504. View

12.

Rush M, Engelhardt B, Parker R, Hazinski T . Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia. J Pediatr. 1990; 117(1 Pt 1):112-8. DOI: 10.1016/s0022-3476(05)82458-8. View

13.

Balasubramaniam V, Maxey A, Fouty B, Abman S . Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol. 2006; 290(6):L1111-6. DOI: 10.1152/ajplung.00431.2005. View

14.

Trotter A, Ebsen M, Kiossis E, Meggle S, Kueppers E, Beyer C . Prenatal estrogen and progesterone deprivation impairs alveolar formation and fluid clearance in newborn piglets. Pediatr Res. 2006; 60(1):60-4. DOI: 10.1203/01.pdr.0000220360.77567.d8. View

15.

Eichenwald E, Stark A . Management and outcomes of very low birth weight. N Engl J Med. 2008; 358(16):1700-11. DOI: 10.1056/NEJMra0707601. View

16.

van der Burg P, de Jongh F, Miedema M, Frerichs I, van Kaam A . Effect of Minimally Invasive Surfactant Therapy on Lung Volume and Ventilation in Preterm Infants. J Pediatr. 2016; 170:67-72. DOI: 10.1016/j.jpeds.2015.11.035. View

17.

Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988; 82(4):527-32. View

18.

Onland W, Offringa M, van Kaam A . Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017; 8:CD002311. PMC: 6483527. DOI: 10.1002/14651858.CD002311.pub4. View

19.

Dargaville P, Kamlin C, De Paoli A, Carlin J, Orsini F, Soll R . The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation. BMC Pediatr. 2014; 14:213. PMC: 4236682. DOI: 10.1186/1471-2431-14-213. View

20.

Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C . Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016; 387(10030):1827-36. DOI: 10.1016/S0140-6736(16)00202-6. View